Impact of COVID-19 pandemic on treatment patterns for stage I Non-Small Cell Lung Cancer in the Netherlands
The pandemic led to a significant increase in radiotherapy for Stage I NSCLC, aligning with prevailing ESMO guidelines. However, this shift persisted post-pandemic when surgical capacity was restored. Short-term outcomes were unchanged.
Authors
- Schelto Kruijff
- Ad F. T. M. Verhagen (ORCID: https://orcid.org/0000-0003-0852-9681)
- Nienke Wolfhagen (ORCID: https://orcid.org/0000-0002-5434-850X)
- J. Belderbos
- Olga C.J. Schuurbiers
- Hans J.M. Smit (ORCID: https://orcid.org/0000-0003-0224-6808)
- W. H. Schreurs (ORCID: https://orcid.org/0000-0001-5050-1434)
- Michel W.J.M. Wouters (ORCID: https://orcid.org/0000-0001-6173-0662)
- Willemijn Y. van der Plas (ORCID: https://orcid.org/0000-0002-5758-2959)
- Ronald Damhuis (ORCID: https://orcid.org/0000-0001-7248-7047)
- Roos M. G. van Vuren
- David J. Heineman (ORCID: https://orcid.org/0009-0002-0720-7015)
Institutions
- Netherlands Comprehensive Cancer Organisation (NL)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1016/j.ctarc.2025.101061
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00